Article

Serologic markers of brain injury and cognitive function after cardiopulmonary bypass.

Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Annals of Surgery (Impact Factor: 7.19). 11/2006; 244(4):593-601. DOI: 10.1097/01.sla.0000239087.00826.b4
Source: PubMed

ABSTRACT To examine the association between biochemical markers of brain injury (MBI) and the inflammatory response in relation to neurocognitive deficiency (NCD) after cardiopulmonary bypass (CPB).
In cardiac surgery, NCD is a common but underdiagnosed complication with an unclear pathophysiology leading to significant morbidity. Despite extensive investigation, identification of a MBI for clinical use and clarifying the pathophysiology of NCD have not been achieved.
Forty patients undergoing CABG and/or valve procedures using CPB were administered a validated neurocognitive battery preoperatively and postoperatively at day 4 and 3 months. S-100b, neuron specific enolase (NSE), and tau protein were assayed as MBIs preoperatively and postoperatively at 6 hours and day 4. C-reactive protein (CRP), interleukin (IL)-6, C3a, and total peroxide levels were also quantified from serum. Impact of cardiotomy suction and antifibrinolytics on markers of brain injury was assessed.
The incidence of early NCD was 40% (16 of 40). NSE and tau protein at the 6-hour time point were both significantly elevated in the presence of NCD (NCD group) compared with those without NCD (NORM group) (8.69 +/- 0.82 vs. 5.98 +/- 0.61; P = 0.018 and 68.8 vs. 29.2%; P = 0.015; respectively). S-100b increase was not different between the NCD and NORM groups. Cardiotomy suction significantly elevated S-100b levels, whereas NSE and tau were not significantly influenced. Aprotinin did not have an effect on NCD or levels of MBIs. Also, the NCD group had significantly elevated CRP and peroxide levels compared with the NORM group at postoperative day 4 while C3a was significantly elevated at 6 hours.
NSE and tau are better associated with NCD and less influenced by cardiotomy suction compared with S-100beta. Inflammatory and oxidative stress is associated with NCD post-CPB.

Download full-text

Full-text

Available from: Frank W Sellke, Jun 20, 2015
0 Followers
 · 
91 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Delirium is the most common complication found in the general hospital setting. Yet, we know relatively little about its actual pathophysiology. This article contains a summary of what we know to date and how different proposed intrinsic and external factors may work together or by themselves to elicit the cascade of neurochemical events that leads to the development delirium. Given how devastating delirium can be, it is imperative that we better understand the causes and underlying pathophysiology. Elaborating a pathoetiology-based cohesive model to better grasp the basic mechanisms that mediate this syndrome will serve clinicians well in aspiring to find ways to correct these cascades, instituting rational treatment modalities, and developing effective preventive techniques.
    Critical Care Clinics 11/2008; 24(4):789-856, ix. DOI:10.1016/j.ccc.2008.06.004 · 2.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Intraoperative Mikroembolien gelten als Ursachen für neuropsychologische Veränderungen nach Koronararterienbypass-Operationen. Zur Neuroprotektion soll eine dynamic bubble trap (DBT) Gasblasen aus der Herz-Lungen-Maschine entfernen und zerebrale Mikroembolien reduzieren. Embol-X-Aortenkanülen sind mit einer Fangvorrichtung ausgestattet, um arteriosklerotische Plaques von den hirnversorgenden Arterien abzuschirmen. In dieser randomisierten Studie wurden eine DBT-Gruppe (n = 50) und eine Embol-X-Gruppe (n = 43) mit einer gemeinsamen Referenzgruppe (n = 50) ohne Filter verglichen. Die Patienten wurden vor sowie drei Monate nach elektiver Koronararterienbypass-Operation mit einer umfangreichen neuropsychologischen Testbatterie und mit einer verkürzten Testung zwei bis vier Tage postoperativ untersucht. In der Magnet-Resonanz-Tomografie wurde postoperativ nach frischen ischämischen Läsionen gesucht. Neurodestruktionsmarker S100B und NSE wurden analysiert. Während der Operation lief eine transkranielle dopplersonografische Aufzeichnung zur Bestimmung der zerebralen Mikroembolisation (MES). Intraoperativ konnte die MES-Gesamtanzahl in der DBT-Gruppe verglichen mit der Kontrollgruppe reduziert werden (z = -2,079; p = 0,019, einseitig), nicht jedoch in der Embol-X-Gruppe (z = -0,483; p = 0,315). Frische ischämische Läsionen wurden zu 13,6% festgestellt. Alle Gruppen verschlechterten sich kurzfristig in allen kognitiven Testbereichen im Vergleich zur Ausgangsuntersuchung (p < 0,001). S100B korrelierte mit frühen Beeinträchtigungen. Drei Monate später zeigte die DBT-Gruppe im Vergleich mit den Kontrollen bessere Ergebnisse in zwei kognitiven Bereichen: Exekutivfunktionen (Buchstaben-Interferenz-Test aus dem Syndromkurztest: t = 2,525; p = 0,007, einseitig) und verbales Gedächtnis (Listenlernen aus dem Verbalen Lern- und Merkfähigkeitstest: t = 2,420; p = 0,009, einseitig). Die Embol-X-Gruppe zeigte keine besseren Ergebnisse. Alle Gruppen waren in den meisten Gedächtnistests auch drei Monate postoperativ beeinträchtigt verglichen mit Baseline (p < 0,001). Beurteilung: Gedächtnisverschlechterungen stellen Nebenwirkungen der Koronararterienbypass-Operation dar. Zerebrale Mikroembolien, sowohl gasförmiger als auch solider Natur, sind mit neuropsychologischen Beeinträchtigungen verbunden. Kein Filterverfahren schützt vollständig neuroprotektiv. Die Reduktion von Gasblasen aus der HLM trägt jedoch zu besseren neuropsychologischen Ergebnissen bei. Depression und Angst erklären postoperative Verschlechterungen nicht. Beeinträchtigungen sind mit höherem Alter, zerebrovaskulären Risikofaktoren, thorakaler Aortenarteriosklerose und zerebralen Vorschäden assoziiert. Cerebral microemboli in coronary artery bypass grafting (CABG) have been reported to contribute to postoperative neuropsychological impairment. In a randomized controlled trial 143 consecutive patients undergoing CABG received either an intra-aortic filter (Embol-X, n = 43), designed to reduce solid microemboli, a dynamic bubble trap (DBT, n = 50), designed to reduce gaseous microemboli, or no additional device (control group, n = 50). Cognitive functioning was assessed before and 2-4 days/ 3 months after CABG. Cerebral MRI was carried out before and after surgery. Biomarker S100B and NSE in serum were analyzed. Microembolic signals (MES) were detected during surgery using transcranial Doppler-sonography. As compared to controls, the total MES-rate was significantly reduced in the DBT-group (z = -2.079; p = 0.019, single-tailed), but not in the Embol-X-group (z = -0.483, p = 0.315). The rate of new ischemic lesions amounted to 13.6% with equal distribution between the groups. All tests revealed cognitive impairment in the early phase after surgery (p < 0.001). S100B was correlated with early decline. Three months afterwards the DBT-group showed improved performance in executive functioning (t = 2.525; p = 0.007, single-tailed) and verbal short-term memory (t = 2.420; p = 0.009, single-tailed), as compared to controls. However, in most memory tests all groups deteriorated from baseline performance (p < 0.001). The Embol-X-group did not show any better outcome as compared to controls. Conclusions: Memory impairment is a side-effect of CABG. Cerebral microemboli of gaseous and solid origin contribute to postoperative decline. No filter-device could protect the brain during CABG completely. However, reduction of gaseous MES has a neuroprotective effect. Cognitive decline is not associated with depression or anxiety but with higher age, cerebrovascular risk factors, aortic arteriosclerosis and previous cerebral damages.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Schizophrenia is a debilitating mental disorder that presents impairments in neurocognition and social cognition. Several studies have suggested that the etiology of schizophrenia can be partly explained by oxidative stress. However, our knowledge about the implications of oxidative stress on illness-related cognitive deficits is still far from being clear. The aim of this work was to study the role of oxidative stress molecules on social cognition and neurocognition in patients with schizophrenia.Methods We assessed the peripheral levels of several molecules associated with oxidative stress, namely nitric oxide (NO), malondialdehyde (MDA), glutathione (GSH), homocysteine, superoxide dismutase (SOD) and neurotrophin 4/5 (NT4/5), in forty¿one patients with schizophrenia and forty-three healthy participants. A battery of tests to measure neurocognition and social cognition was also administered to the schizophrenia group.ResultsWe found that the schizophrenia group presented substantially higher levels of oxidative stress than the control group, as revealed by elevated quantities of the pro-oxidants NO and MDA, and decreased levels of the antioxidants GSH, SOD and NT4/5. Interestingly, the levels of NT4/5, which have been shown to have antioxidant effects, correlated with executive functioning, as measured by two distinct tests (WCST and TMT). However, social cognition and symptom severity were not found to be associated with oxidative stress.Conclusions We propose a protective role of NT4/5 against oxidative stress, which appears to have a potentially beneficial impact on neurocognition in schizophrenia.
    BMC Psychiatry 09/2014; 14(1):268. DOI:10.1186/s12888-014-0268-x · 2.24 Impact Factor